| |
 |
Chromosomal Aberrations and Genomic Instability Induced by Topoisomerase- Targeted Antitumour Drugs
|
| |
|
pp.317-325 (9) Authors: Francesca Degrassi, Mario Fiore, Fabrizio Palitti |
| |
|
|
| |
 |
Topoisomerase I-DNA Complex Stability Induced by Camptothecins and Its Role in Drug Activity
|
| |
|
pp.327-334 (8) Authors: Randy M. Wadkins, David Bearss, Govindarajan Manikumar, Mansukhlal C. Wani, Monroe E. Wall, Daniel D. Von Hoff |
| |
|
|
| |
 |
Development of DNA Topoisomerase-Related Therapeutics: A Short Perspective of New Challenges
|
| |
|
pp.335-345 (11) Authors: Giovanni Capranico, Giuseppe Zagotto, Manlio Palumbo |
| |
|
|
| |
 |
Recent Advances in Experimental Molecular Therapeutics for Malignant Gliomas
|
| |
|
pp.347-361 (15) Authors: Gautam Prasad, Hui Wang, Donald L. Hill, Ruiwen Zhang |
| |
|
|
| |
 |
Lamellarins, from A to Z: A Family of Anticancer Marine Pyrrole Alkaloids
|
| |
|
pp.363-378 (16) Author: Christian Bailly |
| |
|
|
| |
 |
Effect of Prostaglandins on the Regulation of Tumor Growth
|
| |
|
pp.379-387 (9) Authors: Shunji Ishihara, M A.K. Rumi, Toshihiko Okuyama, Yoshikazu Kinoshita |
| |
|
|